Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pharmaceutics|December 31, 2025
Exploring Anti-Neoplastic Activity of Chitosan Nanobubbles Decorated with ICOS-Fc and Loaded with Paclitaxel in a Human and Murine Model of MelanomaDeepika Pantham, Monica Argenziano, Foteini Christaki, et al.
Pharmaceutics|June 28, 2023
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of InflammationChiara Puricelli, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Pharmaceutics|March 29, 2023
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical ApplicationsElena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Cell Communication and Signaling : CCS|November 27, 2025
ICOSL: more than a trigger of ICOS functionIan Stoppa, Alessia Provera, Sara Sacchetti, et al.
Nanomaterials (Basel, Switzerland)|December 11, 2022
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma TreatmentChiara Monge, Ian Stoppa, Chiara Ferraris, et al.
International Journal of Molecular Sciences|July 9, 2022
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In VivoIan Stoppa, Casimiro Luca Gigliotti, Nausicaa Clemente, et al.
International Journal of Molecular Sciences|November 27, 2024
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound HealingFoteini Christaki, Amirabbas Ghasemi, Deepika Pantham, et al.
Frontiers in Immunology|December 11, 2023
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitisAlessia Provera, Naresh Naik Ramavath, Laila Lavanya Gadipudi, et al.
British Journal of Haematology|December 26, 2021
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironmentElena Boggio, Casimiro Luca Gigliotti, Riccardo Moia, et al.
Frontiers in Immunology|September 19, 2022
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsisGustavo Ferreira Alves, Ian Stoppa, Eleonora Aimaretti, et al.
Pageof 2